Home » Topics » Disease categories and therapies » Immune

Immune
RSS

DOR BioPharma signs partnering agreement with Sigma-Tau for orBec

Feb. 13, 2009

Enzon discontinues rhMBL development

Feb. 11, 2009

Cell-based gene therapy effective in SCID due to ADA deficiency

Feb. 9, 2009

Toxicity seen with everolimus/tacrolimus regimen in stem cell transplant patients

Feb. 6, 2009

Bortezomib effective in treating renal transplant rejection

Feb. 2, 2009

European Commission withdraws marketing authorization for Roche's Zenapax

Jan. 26, 2009

Mitsubishi Tanabe Pharma claims novel amine compounds for autoimmune diseases

Jan. 23, 2009

Juvaris presents positive data from JVRS-100 adjuvanted flu vaccine trial

Jan. 12, 2009

Quark doses first patient in phase I/II QPI-1002 trial for delayed graft function

Jan. 12, 2009

MenACWY-TT meningococcal vaccine immunogenic in adolescents

Jan. 12, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...